• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

La Jolla Pharmaceutical Company - Common Stock (NQ:LJPC)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 19, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 4.000 (1)
Ask (Size) 6.250 (9)
Prev. Close 6.220
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 24,936,883
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Innoviva Completes Acquisition of La Jolla Pharmaceutical
August 22, 2022
From Innoviva, Inc.
Via Business Wire
LJPC Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of La Jolla Pharmaceutical Company Is Fair to Shareholders
July 28, 2022
From Halper Sadeh LLP
Via Business Wire

Performance

More News

Read More
LA JOLLA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of La Jolla Pharmaceutical Company - LJPC
July 11, 2022
From Kahn Swick & Foti, LLC
Via Business Wire
Alibaba, Zoom Video And 76 Biggest Movers From Yesterday
July 12, 2022
Via Benzinga
Dow Dips Around 90 Points; La Jolla Pharmaceutical Shares Surge
July 11, 2022
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
July 11, 2022
Via Benzinga
Nasdaq Tumbles 2%; Pliant Therapeutics Shares Spike Higher
July 11, 2022
Via Benzinga
Why These Casino Stocks Are Moving Lower, Here's 45 Stocks Moving In Monday's Mid-Day Session
July 11, 2022
Via Benzinga
5 Top Short Squeeze Stocks to Watch This Week
July 11, 2022
Via InvestorPlace
La Jolla Pharmaceutical (LJPC) Stock Skyrockets on Innoviva Acquisition News
July 11, 2022
Via InvestorPlace
Why U.S. Stocks Are Trading Lower; AZZ Earnings And More
July 11, 2022
Via Benzinga
The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After Patient Death
July 11, 2022
Via Benzinga
LJPC Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of La Jolla Pharmaceutical Company Is Fair to Shareholders
July 11, 2022
From Halper Sadeh LLP
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 11, 2022
Via Benzinga
Innoviva Bolsters Its Infectious Disease, Hospital Portfolio With La Jolla Deal
July 11, 2022
Via Benzinga
Innoviva to Acquire La Jolla Pharmaceutical Company
July 11, 2022
From La Jolla Pharmaceutical Company
Via Business Wire
Recap: La Jolla Pharmaceutical Q1 Earnings
May 16, 2022
Via Benzinga
La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Corporate Progress
May 16, 2022
From La Jolla Pharmaceutical Company
Via Business Wire
5 Value Stocks To Watch In The Healthcare Sector
March 21, 2022
Via Benzinga
La Jolla Pharmaceutical Company Announces Share Repurchase Plan
November 17, 2021
From La Jolla Pharmaceutical Company
Via Business Wire
50 Biggest Movers From Yesterday
November 30, 2021
Via Benzinga
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2021 and Highlights Corporate Progress
November 04, 2021
From La Jolla Pharmaceutical Company
Via Business Wire
Tony Hodges, M.D., FACP, FCCP, Appointed Chief Medical Officer of La Jolla Pharmaceutical Company
September 10, 2021
From La Jolla Pharmaceutical Company
Via Business Wire
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2021 and Highlights Corporate Progress
August 05, 2021
From La Jolla Pharmaceutical Company
Via Business Wire
99 Biggest Movers From Yesterday
August 06, 2021
Via Benzinga

Frequently Asked Questions

Is La Jolla Pharmaceutical Company - Common Stock publicly traded?
Yes, La Jolla Pharmaceutical Company - Common Stock is publicly traded.
What exchange does La Jolla Pharmaceutical Company - Common Stock trade on?
La Jolla Pharmaceutical Company - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for La Jolla Pharmaceutical Company - Common Stock?
The ticker symbol for La Jolla Pharmaceutical Company - Common Stock is LJPC on the Nasdaq Stock Market
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap